Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
SHEEL
SHEEL
60.05+0.0 (+0.00%)
22 Oct, 12:00 AM

Stock Scores

Quality Score

21.1 / 100

Value Score

77.5 / 100

Price Momentum Score

33.1 / 100

QVM Score

34.0 / 100

Key Metrics

Market Cap
122.22
P/E (TTM)
10.40
P/B
0.96
P/S (TTM)
1.11
EV/EBITDA
7.92
CAPE (5Y)
13.78
ROE (TTM)
7.98
ROCE (TTM)
12.83
ROA (TTM)
9.08
Avg 3Y ROE
10.75
Earnings 3Y CAGR
38.94
Sales 3Y CAGR
11.15
Sales 5Y CAGR
-
Debt/Equity
0.07
Consensus TP
-
Strong Buy %
-
Promoter Holding
72.31
Pledged %
0.00

Share Price

Track Sheel Biotech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

60.050.0 (0.00%) D
-28.34% in past 1 year
1 Week returns: -3.92 %
Low
60.0
High
60.0
1 Month returns: 3.53 %
Low
57.0
High
63.3
1 Year returns: -28.34 %
Low
37.8
High
86.5
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Sheel Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 10.4 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -28.67%

What is P/E Ratio?

Median: 14.58
Value 10.4
-781.72459.51
Negative
Company's earnings are of low quality

Earnings quality score of 20.4 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

20.4 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0817832.

Financial Snapshot

See detailed analysis

Multi-year trends for Sheel Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k101.8 CrMar 2025110.0 CrMar 2026
Profit After Tax FY
00k0k0k10.6 CrMar 202511.8 CrMar 2026
ROE FY
0%5%10%8.8%Mar 20258.0%Mar 2026
EBITDA FY
00k0k0k0k15.0 CrMar 202516.3 CrMar 2026

Sheel Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Sheel Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2026Sep 2026
Total Promoter
72.29
72.31
Indian Promoter
72.29
72.31
Foreign Promoter
-
-
Institutions
9.49
9.66
Mutual Funds / UTI
-
-
FI/Bank/Insurance
0.00
0.00
Govt
-
-
FII
0.00
0.00
Other Institutions
9.49
9.66
Non-Institution
18.22
18.03
Bodies Corporate
4.82
3.18
Others (incl. Retail)
No. of shareholders
13.40
347
14.85
327

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sheel Biotech Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
BAKUL CHATURBHAI LIMBASIYA18 Jun 2026buy₹ 72.901.50 lac₹ 1.09 cr
LONGVIEW RESEARCH AND ADVISORY SERVICES PRIVATE LIMITED16 Feb 2026buy₹ 63.331.02 lac₹ 64.60 lac
SHUBHAM SANJAY DAMANI16 Feb 2026sell₹ 63.571.16 lac₹ 73.74 lac
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED13 Oct 2025buy₹ 82.001.30 lac₹ 1.07 cr
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED13 Oct 2025sell₹ 82.0060.00 k₹ 49.20 lac
CRAFT EMERGING MARKET FUND PCC- CITADEL CAPITAL FUND08 Oct 2025sell₹ 91.001.36 lac₹ 1.24 cr
LONGTHRIVE CAPITAL VCC - GAMMA VIEW FUNDS08 Oct 2025sell₹ 91.231.06 lac₹ 96.70 lac
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED08 Oct 2025buy₹ 95.5560.00 k₹ 57.33 lac
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED08 Oct 2025sell₹ 92.061.22 lac₹ 1.12 cr
PREETI BHAUKA08 Oct 2025buy₹ 91.001.34 lac₹ 1.22 cr

No corporate action data available.

Company Profile

Overview of Sheel Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Sheel Biotech Limited is an India-based company, which is engaged in the business of growing, developing, processing, and supplying a range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The Companys business vertical includes tissue ...
Key personnel
Ms. Surbhi
Chief Financial Officer
Mr. Anupam Pandey
Company Secretary, Compliance Officer
Mr. Satya Narayan ChandakD
Executive Chairman of the Board
Mr. Divye ChandakD
Managing Director, Executive Director
Dr. Sanjay ChandakD
Executive Director
Ms. Mini ChadhaD
Non-Executive Director
Mr. Shyamsundar BangD
Non-Executive Independent Director
Mr. Atul KumarD
Non-Executive Independent Director
View all
Incorporated on
26 Nov 1991
Last Annual
31 Mar 2026
Last Interim
-
No. of Employees
146
IPO date
-
Free Float
-
Phone no.
+918851189801
Address
Sheel Biotech Limited, 2nd Floor, Guru, Tower C, Guru Ravidas Marg, Balaji Estate, Kalkaji, NEW DELHI, 110019, India

Frequently Asked Questions

What is the current share price of Sheel Biotech Ltd.?
The current share price of Sheel Biotech Ltd. is ₹ 60.05 as of 22 Oct 2026.
What is the market capitalisation of Sheel Biotech Ltd.?
The market capitalisation of Sheel Biotech Ltd. stands at ₹ 122.22 Cr.
What is the PE ratio of Sheel Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Sheel Biotech Ltd. is 10.40 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sheel Biotech Ltd.?
Sheel Biotech Ltd. has a Return on Equity (ROE) of 7.98% and a Return on Capital Employed (ROCE) of 12.83% as per the latest financial reports.
What is the 52-week high and low of Sheel Biotech Ltd.?
The 52-week high of Sheel Biotech Ltd. is - and the 52-week low is -.
What is the dividend yield of Sheel Biotech Ltd.?
The dividend yield of Sheel Biotech Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Sheel Biotech Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 14.85% of Sheel Biotech Ltd. shares.
What sector does Sheel Biotech Ltd. belong to?
Sheel Biotech Ltd. operates in the Services sector.
What is the beta of Sheel Biotech Ltd.?
The beta of Sheel Biotech Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Sheel Biotech Ltd.?
The 14-day Relative Strength Index (RSI) of Sheel Biotech Ltd. is 46.90, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.